CYP2D6 and breast cancer: The debate on the clinical relevance of the TAM-CYP2D6 drug-gene interaction has not yet been resolved as there are conflicting results from different studies on the role of the CYP2D6 genotype on the clinical outcomes of breast cancer treatment.